X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2829) 2829
Publication (162) 162
Book Review (69) 69
Book Chapter (49) 49
Magazine Article (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Newsletter (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1553) 1553
humans (1485) 1485
direct oral anticoagulants (1092) 1092
anticoagulants (995) 995
warfarin (926) 926
dabigatran (853) 853
direct thrombin inhibitor (767) 767
rivaroxaban (766) 766
venous thromboembolism (726) 726
atrial fibrillation (688) 688
hematology (656) 656
anticoagulants - therapeutic use (591) 591
administration, oral (567) 567
peripheral vascular disease (533) 533
male (485) 485
apixaban (460) 460
female (429) 429
dabigatran etexilate (424) 424
atrial-fibrillation (421) 421
stroke (419) 419
anticoagulants - administration & dosage (417) 417
anticoagulants - adverse effects (408) 408
thromboembolism (405) 405
pharmacology & pharmacy (401) 401
cardiac & cardiovascular systems (388) 388
prevention (367) 367
aged (353) 353
thrombin (326) 326
anticoagulation (318) 318
thrombosis (307) 307
middle aged (280) 280
risk factors (276) 276
bleeding (267) 267
pharmacokinetics (267) 267
atrial fibrillation - drug therapy (264) 264
direct oral anticoagulant (257) 257
hemorrhage - chemically induced (257) 257
management (252) 252
treatment outcome (249) 249
safety (248) 248
medicine & public health (247) 247
molecular-weight heparin (246) 246
direct thrombin inhibitors (243) 243
medicine, general & internal (243) 243
stroke prevention (241) 241
blood coagulation - drug effects (231) 231
analysis (230) 230
factor xa inhibitors (230) 230
stroke - prevention & control (221) 221
surgery (217) 217
therapy (216) 216
factor xa inhibitor (213) 213
factor-xa inhibitor (211) 211
anticoagulants - pharmacology (210) 210
deep-vein thrombosis (208) 208
risk (205) 205
antithrombotic therapy (204) 204
oral anticoagulants (197) 197
patients (197) 197
adult (196) 196
heparin (194) 194
care and treatment (193) 193
pharmacodynamics (193) 193
atrial fibrillation - complications (188) 188
edoxaban (187) 187
aged, 80 and over (181) 181
cardiology (176) 176
animals (174) 174
nonvalvular atrial-fibrillation (174) 174
drug therapy (173) 173
double-blind (169) 169
prothrombin complex concentrate (167) 167
hemorrhage (161) 161
thrombin - antagonists & inhibitors (153) 153
cardiac arrhythmia (148) 148
ximelagatran (147) 147
internal medicine (146) 146
abridged index medicus (143) 143
beta-alanine - analogs & derivatives (141) 141
health aspects (141) 141
clinical trials (139) 139
enoxaparin (138) 138
anticoagulants - pharmacokinetics (137) 137
vitamin k - antagonists & inhibitors (135) 135
pulmonary embolism (133) 133
warfarin - therapeutic use (131) 131
medical research (128) 128
reversal (128) 128
venous thromboembolism - drug therapy (128) 128
thromboembolism - prevention & control (127) 127
coagulation (126) 126
vitamin k antagonists (126) 126
stroke - etiology (125) 125
efficacy (123) 123
dosage and administration (122) 122
mortality (120) 120
review (120) 120
benzimidazoles - therapeutic use (119) 119
medicine, experimental (118) 118
antithrombins - therapeutic use (117) 117
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2619) 2619
German (86) 86
French (76) 76
Spanish (35) 35
Russian (25) 25
Japanese (24) 24
Hungarian (7) 7
Italian (6) 6
Czech (4) 4
Polish (4) 4
Arabic (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 1, pp. 15 - 20
Journal Article
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 02/2013, Volume 34, Issue 7, pp. 489 - 500
Novel oral anticoagulants that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban) are currently available for prevention of venous... 
Novel oral anticoagulants | Bleeding | Management | RECOMBINANT FACTOR-VIIA | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | RANDOMIZED EVALUATION | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | FACTOR-XA INHIBITOR | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | PROTHROMBIN COMPLEX CONCENTRATE | NONVALVULAR ATRIAL-FIBRILLATION | Plasma | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Antithrombins - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | beta-Alanine - pharmacology | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Acute Disease | beta-Alanine - adverse effects | Administration, Oral | Morpholines - administration & dosage | Risk Factors | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Anticoagulants - pharmacology | Antithrombins - adverse effects | Blood Coagulation Tests | Benzimidazoles - pharmacology | Aged | Hemostatics - therapeutic use | Pyridones - adverse effects | Pyridones - pharmacology | Renal Dialysis
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 5, pp. 495 - 511
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 1, pp. 27 - 28
In the pivotal phase III RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, which involved 18,113 patients with atrial fibrillation... 
dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | vitamin K antagonist | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | EFFICACY | SAFETY | RISK | ATRIAL-FIBRILLATION | WARFARIN | Anticoagulants | Dust | Myocardial Infarction | Dabigatran | Atrial Fibrillation | Humans | Myocardial infarction | Stroke | Mortality | Cardiovascular disease | Infarction | Health risk assessment
Journal Article